Showing results (1621-1630 of 3,871) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|October 3, 2006
Furanonaphthoquinones cause apoptosis of cancer cells by inducing the production of reactive oxygen species by the mitochondrial voltage-dependent anion channelEriko Simamura, Kei-Ichi Hirai, Hiroki Shimada, et al.Cancer Biology & Therapy|July 22, 2008
Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancerMichele J Hoffmann, Rainer Engers, Andrea R Florl, et al.Cancer Biology & Therapy|March 10, 2009
Increase of telomerase activity and hTERT expression in myelodysplastic syndromesFederica Briatore, Giuseppina Barrera, Stefania Pizzimenti, et al.Cancer Biology & Therapy|March 10, 2009
Cisplatin-damaged BRCA1 exhibits altered thermostability and transcriptional transactivationAdisorn Ratanaphan, Siriwat Wasiksiri, Bhutorn Canyuk, et al.Cancer Biology & Therapy|March 10, 2009
NCI designated cancer center funding not influenced by organizational structureMargaret E Wolfe, Daniel Yagoda, Paul W Thurman, et al.Cancer Biology & Therapy|March 10, 2009
T351 protein, a novel tumor associated antigen and potential target for immunotherapyJunhai Lu, Ning Kang, Lianxian Cui, et al.Cancer Biology & Therapy|March 10, 2009
Comparitive study of efficacy, tolerability of four field box technique vs. two field anterior posterior technique in locally advanced carcinoma cervix--a prospective analysisDeepak Gupta, Pragya Shukla, Shyam Singh Bisht, et al.Cancer Biology & Therapy|March 10, 2009
Bcl-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stressGirija Dasmahapatra, Dmitry Lembersky, Mohamed Rahmani, et al.Cancer Biology & Therapy|March 12, 2009
RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticlesGuopei Luo, Chen Jin, Jiang Long, et al.Cancer Biology & Therapy|March 12, 2009
Histopathological analyses of the antitumor activity of anti-glypican-3 antibody (GC33) in human liver cancer xenograft models: The contribution of macrophagesHirotake Takai, Atsuhiko Kato, Yasuko Kinoshita, et al.Pageof 388